explore -WSS

explore

author：comprehensive 2025-10-01 21:37:30 - browse：74

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

WSS

After Sarepta trial failure, Duchenne families brace for more debate

Kidney transplant patients stopped immunosuppressants in trial

New Covid vaccine is recommended for everyone 6 months or older

IRA could hurt research into orphan drugs for rare diseases

WATCH: Why do bright lights make us see spots?

Life sciences investors close nearly $6 billion in new funds

leisure time

explore

hotspot

Affirmative action in medical school literally saved lives

WATCH: Why do bright lights make us see spots?

United colonoscopy coverage change 'may cost lives,' doctors say

How medical schools plan to diversify without affirmative action

Anesthesiologist group: stop taking Ozempic before surgery

Life sciences investors close nearly $6 billion in new funds

BioMarin wins approval for gene therapy to treat hemophilia A

Humans aren't the only ones with an imagination. Rats have it too

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

WATCH: Why do bright lights make us see spots?

entertainment

Live blog: Hearing on CRISPR

FDA proposes changes to key medical devices approval pathway

Long Covid needs a new name — and a new frame

Popular nasal decongestant doesn't actually relieve congestion

Will the IRA bring competition to the biologics market?

Bill would allow buprenorphine prescription for addiction via telehealth

explore

knowledge

leisure time

entertainment